News Conference News ACC 2026 HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE L.A. McKeown March 28, 2026
Presentation THT 2026 Perioperative Management and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation: A Case Series Presenter: Vaidehi Mendpara March 02, 2026
News Conference News EAPCI 2026 SCAD-Related MI Not Just the Domain of Young Women: Serbian Registry Caitlin E. Cox February 27, 2026
News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News ESC 2025 ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD L.A. McKeown September 09, 2025
News Conference News NY Valves 2025 No Benefit of Sentinel Device During TAVI: Updated Meta-analysis Todd Neale July 04, 2025
News Daily News Patchy Anticoagulation Use During COVID Pandemic Raises Questions L.A. McKeown March 06, 2025
Presentation THT 2025 Medical Management (Heparin/ Lytics) Presenter: Gregory Piazza February 12, 2025
News Conference News ISC 2025 Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 11, 2025
Presentation TCT 2024 TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study Presenter: Neethi Dasu October 30, 2024
News Conference News TCT 2024 In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI Yael L. Maxwell October 29, 2024
News Conference News TCT 2024 PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE Todd Neale October 29, 2024
Presentation TCT 2024 TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis Presenter: Hamza Naveed October 28, 2024
Presentation TCT 2024 TCT 934: Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial Presenter: Jing Chen October 28, 2024
Presentation TCT 2024 Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial Presenter: Jing Chen October 28, 2024
Presentation TCT 2024 Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial Presenter: Jing Chen October 28, 2024
Presentation TCT 2024 TCT 182: Impact of Heparin-Induced Thrombocytopenia (HIT) on Outcomes in TAVR Patients: A Comprehensive Analysis Presenter: Neethi Dasu October 27, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI Todd Neale August 31, 2024
News Daily News ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions Caitlin E. Cox August 16, 2024